JY
FLGT icon

Jeff Yass’s Fulgent Genetics FLGT Stock Holding History

Jeff Yass’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Sell
13,100
-2,000
-13% -$33.9K ﹤0.01% 11294
2026
Q1 		$240K Sell
15,100
-3,800
-20% -$82.5K ﹤0.01% 11350
2025
Q4 		$497K Buy
+18,900
New +$490K ﹤0.01% 8804
2025
Q2 		– Sell
-13,900
Closed -$235K – 12954
2025
Q1 		$235K Buy
13,900
+500
+4% +$8.52K ﹤0.01% 10603
2024
Q4 		$247K Buy
+13,400
New +$262K ﹤0.01% 10234
2024
Q3 		– Sell
-10,100
Closed -$198K – 12291
2024
Q2 		$198K Sell
10,100
-31,800
-76% -$664K ﹤0.01% 10369
2024
Q1 		$909K Buy
41,900
+11,200
+36% +$278K ﹤0.01% 7139
2023
Q4 		$888K Buy
30,700
+8,800
+40% +$235K ﹤0.01% 7282
2023
Q3 		$586K Sell
21,900
-32,600
-60% -$1.11M ﹤0.01% 7861
2023
Q2 		$2.02M Buy
54,500
+6,800
+14% +$237K ﹤0.01% 5143
2023
Q1 		$1.49M Sell
47,700
-45,600
-49% -$1.47M ﹤0.01% 5821
2022
Q4 		$2.78M Sell
93,300
-60,800
-39% -$2.18M ﹤0.01% 4136
2022
Q3 		$5.87M Sell
154,100
-44,900
-23% -$2.25M ﹤0.01% 2914
2022
Q2 		$10.9M Sell
199,000
-6,800
-3% -$374K ﹤0.01% 2102
2022
Q1 		$12.8M Sell
205,800
-16,500
-7% -$1.09M ﹤0.01% 2227
2021
Q4 		$22.4M Sell
222,300
-82,200
-27% -$7.22M ﹤0.01% 1743
2021
Q3 		$27.4M Sell
304,500
-67,500
-18% -$6.13M ﹤0.01% 1673
2021
Q2 		$34.3M Buy
372,000
+36,700
+11% +$2.93M ﹤0.01% 1487
2021
Q1 		$32.4M Buy
335,300
+161,900
+93% +$16.7M 0.01% 1421
2020
Q4 		$9.03M Buy
173,400
+126,400
+269% +$5.28M ﹤0.01% 2619
2020
Q3 		$1.88M Buy
+47,000
New +$1.47M ﹤0.01% 4738

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's FLGT Position: Q2 2026 in Review

Jeff Yass reduced its Fulgent Genetics (FLGT) stake by 20% in Q2 2026, selling an estimated $130K and leaving 30,405 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #9385.

Jeff Yass first reported a position in FLGT in Q1 2018 and has held it in 26 quarters since. The position peaked at $15.2M in Q2 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Jeff Yass held 30,405 shares of Fulgent Genetics worth $624K as of Q2 2026.
  • Jeff Yass sold 7,673 Fulgent Genetics shares in Q2 2026, an estimated $130K.
  • Fulgent Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9385 holding.
  • Jeff Yass first reported a position in Fulgent Genetics in Q1 2018 and has held it in 26 quarters since.
  • Jeff Yass's Fulgent Genetics position peaked at $15.2M in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.